IONQ.NYSEIonq, INC

Form 4: IonQ Director Exercises Options, Sells Shares

Sentiment:

Insider Transaction Report


IonQ Director Kathryn K. Chou exercised stock options and sold an equal number of shares on December 22, 2025, under a pre-arranged trading plan.

Summary

  • Director Kathryn K. Chou acquired 5,000 shares of IonQ common stock by exercising stock options at $4.61 per share.
  • Simultaneously, Chou sold 5,000 shares of IonQ common stock at $55 per share.
  • These transactions occurred on December 22, 2025, and were executed under a Rule 10b5-1 trading plan adopted on September 11, 2025.
  • Following these transactions, Chou directly owns 60,839 shares of common stock and 19,900 stock options.
  • The exercised option was part of an original grant for 63,900 shares, which vested in three equal annual installments starting July 11, 2023.

Sentiment

Score: 7

Explanation: The director realized a substantial gain from exercising options and selling shares, which is positive for the individual. The transaction was pre-planned under a 10b5-1 plan, which mitigates concerns about opportunistic selling. However, a director selling shares, even pre-planned, can sometimes be viewed with slight caution by investors.

Positives

  • Director Chou realized a significant gain by selling shares at $55 after exercising options at $4.61.
  • The transactions were conducted under a Rule 10b5-1 trading plan, indicating they were pre-planned and not based on inside information.

Negatives

  • The sale of shares by a director, even if pre-planned, reduces their direct equity exposure in the company.

Future Outlook

N/A. This filing reports past transactions and does not provide forward-looking statements or guidance.

Industry Context

N/A. This Form 4 filing details an individual director's stock transactions and does not provide broader industry context.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantKathryn K. Chou granted a Power of Attorney to Paul Dacier, Tyler Rosenbaum, Inder Singh, and Kevin Caimi to prepare, execute, and submit SEC Forms 3, 4, and 5 on her behalf.2025-10-22Streamlines the process for filing required insider transaction reports for the director, ensuring timely compliance with Section 16(a) of the Exchange Act.

Stakeholder Impact

  • Shareholders: The sale of shares by a director, even under a 10b5-1 plan, might be viewed by some as a slight reduction in insider alignment, though the pre-planned nature mitigates negative interpretations.

Key Dates

DateDescription
2023-07-11Commencement of vesting for the stock option, which vested in three equal annual installments.
2025-09-11Date the Rule 10b5-1 trading plan was adopted by Kathryn K. Chou.
2025-10-22Effective date of the Power of Attorney granted by Kathryn K. Chou.
2025-12-22Date of stock option exercise and common stock sale transactions.
2025-12-23Date the Form 4 was signed by Power of Attorney.
2032-07-11Expiration date of the stock option.

Recommendation

hold

The filing details a routine insider transaction where a director exercised stock options and sold an equivalent number of shares under a pre-arranged 10b5-1 trading plan. While the director realized a substantial gain, this is a personal financial event and does not reflect new information about the company's operational performance or future prospects. The pre-planned nature of the transaction suggests it's not based on new, material non-public information. Therefore, it provides no new fundamental reason to alter an existing investment thesis, warranting a 'hold' recommendation.

Keywords

IonQ, IONQ, Kathryn K. Chou, Form 4, Insider Trading, Stock Option Exercise, Share Sale, Rule 10b5-1 Plan, Director Transaction, Quantum Computing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.